Fujisawa Seiichiro, Kadoma Yoshinori
Department of Diagnostic and Therapeutic Science, Meikai University School of Dentistry, Saitama 350-0283, Japan.
Anticancer Res. 2005 Nov-Dec;25(6B):3989-94.
Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) is now under active investigation as a neuroprotective and anticancer agent. In the present study, the induction period method was used to investigate the antioxidant activity of ebselen in the radical polymerization of methyl methacrylate (MMA) at 70 degrees C. The reaction of ebselen with growing MMA radicals (lipid radicals) showed a k(inh) of 4 x 10(4) M(-1)s(-1). This value was similar to that for mercaptomethylimidazole (MMI, a thiol) and 10-fold greater than that for butylated hydroxyanisole (BHA). The ratio of the rate of chain inhibition to that of chain propagation (CI/CP) for ebselen, MMI and BHA was 0.1, 0.01 and 0.001, respectively, whereas the stoichiometric factor (n, the number of free radicals trapped by one mole of antioxidant moiety) for the corresponding compounds was 0.02, 0.2 and 2, respectively. Ebselen preferentially affected CP rather than CI, indicating that it was an effective scavenger (suppressor) of growing MMA radicals. These results suggest that ebselen is a potent suppressor of polyunsaturated fatty acid (PUFA) radicals, which are harmful radicals in biological systems.
依布硒啉(2-苯基-1,2-苯并异硒唑-3(2H)-酮)作为一种神经保护剂和抗癌剂目前正在积极研究中。在本研究中,采用诱导期法研究了依布硒啉在70℃下甲基丙烯酸甲酯(MMA)自由基聚合反应中的抗氧化活性。依布硒啉与增长的MMA自由基(脂质自由基)的反应显示出4×10⁴ M⁻¹ s⁻¹的抑制常数(k(inh))。该值与巯基甲基咪唑(MMI,一种硫醇)的值相似,比丁基羟基茴香醚(BHA)的值大10倍。依布硒啉、MMI和BHA的链抑制速率与链增长速率之比(CI/CP)分别为0.1、0.01和0.001,而相应化合物的化学计量系数(n,一摩尔抗氧化剂部分捕获的自由基数量)分别为0.02、0.2和2。依布硒啉优先影响链增长而非链抑制,表明它是增长的MMA自由基的有效清除剂(抑制剂)。这些结果表明依布硒啉是多不饱和脂肪酸(PUFA)自由基的有效抑制剂,PUFA自由基是生物系统中的有害自由基。